The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases
Loading...
Identifiers
Publication date
Authors
Zilli, Thomas
Dirix, Piet
Heikkilä, Reino
Liefhooghe, Nick
Siva, Shankar
Advisors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Abstract
Optimal local treatment for nodal oligorecurrent prostate cancer is unknown. The randomized phase 2 PEACE V-STORM trial will explore the best treatment approach in this setting. Early results on the acute toxicity profile are projected to be published in quarter 3, 2021.
Description
UNESCO Subjects
Keywords
Bibliographic reference
Zilli, T., Dirix, P., Heikkilä, R., Liefhooghe, N., Siva, S., Gómez-Iturriaga, A., Everaerts, W., Otte, F., Shelan, M., Mercier, C., Achard, V., Thon, K., Stellamans, K., Moon, D., Conde-Moreno, A., Papachristofilou, A., Scorsetti, M., Gückenberger, M., Ameye, F., Zapatero, A., … Ost, P. (2021). The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases. European Urology Focus, 7(2), 241–244. https://doi.org/10.1016/j.euf.2020.12.010